[CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)]
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Karim A, Elfellah M, Evans D J Med Genet. 1981; 18(5):325-30.
PMID: 7328611 PMC: 1048751. DOI: 10.1136/jmg.18.5.325.
Neumann G Beitr Klin Erforsch Tuberk Lungenkr. 1969; 140(1):157-76.
PMID: 5824364
Chicou F, HETRICK G, Huet M, Radenac H, RIST N Bull World Health Organ. 1968; 39(5):731-69.
PMID: 4183287 PMC: 2554438.
References
1.
BROUET G, MARCHE J, RIST N, Chevallier J, LEMEUR G
. Observations on the antituberculous effectiveness of alpha-ethyl-thioisonicotinamide in tuberculosis in humans. Am Rev Tuberc. 1959; 79(1):6-18.
DOI: 10.1164/artpd.1959.79.1.6.
View
2.
CHICOU J, HETRICK G, Lahlou M, Le Hir M, MERCIEP A, NEEL R
. [Controlled investigation of 3 types of oral treatment of pulmonary tuberculosis made in Morocco, at Tangiers (I.N.H. with ethioniamide; I.N.H. with PAS; I.N.H. alone). (Early results after 1 year of observation)]. Rev Tuberc Pneumol (Paris). 1961; 25:1031-56.
View
3.
Fox W
. Ambulatory chemotherapy in a developing country: clinical and epidemiological studies. Bibl Tuberc. 1963; 17:28-149.
View